Clinical Trials Directory

Trials / Terminated

TerminatedNCT00334217

Cognitive Remediation in Early Substance Abuse Treatment

Cognitive Remediation in the Initial Phase of Substance Abuse Treatment: Feasibility and Efficacy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is for the purpose of determining whether cognitive remediation may improve cognition and treatment response in patients entering substance abuse day treatment

Detailed description

Background: Patients entering substance abuse treatment display cognitive deficits that may reduce their ability to benefit from their treatment. While there is considerable variety in the severity and types of cognitive impairment found in newly recovering patients, problems with attention, memory and executive function are very common. Since treatment requires sustained attention, remembering what is learned, integrating that knowledge and applying it to recovery, impairment in underlying cognitive processes makes successful treatment less likely. Although cognitive functioning improves with sustained sobriety, it is during the early phase of recovery that most patients receive the most intensive treatment. Recent research has suggested that cognitive remediation exercises during this early phase may speed up the return of cognitive functioning and in so doing may have a direct effect on whether patients find the treatment useful and complete their treatment. By keeping patients in treatment longer, cognitive remediation may have an indirect effect on substance abuse outcomes. Objectives: To pilot test the introduction of cognitive remediation at the Substance Abuse Day Treatment Program (SADP) at the Errara Community Care Center. Aims are 1) to assess the receptivity of patients to the intervention by determining rates of agreement to participate, 2) to determine the number of cognitive remediation sessions that patients are willing to engage in, 3) to assess a variety of cognitive remediation tasks for their acceptability, 4) to evaluate neuropsychological improvements using pre-post assessment, 5) to evaluate its effects on substance abuse treatment participation, and 6) to evaluate its effects on substance abuse outcomes at 6 months follow-up. Design: Randomized clinical trial of cognitive remediation with an active control condition with observations at baseline, end of treatment and 6-months from intake

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive RemediationPSS Cogrehab

Timeline

Start date
2005-08-01
Primary completion
2007-08-01
Completion
2008-12-01
First posted
2006-06-06
Last updated
2009-06-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00334217. Inclusion in this directory is not an endorsement.